Efficacy and Safety of DMB-I (INN: Latrepirdine) in Patients With Alzheimer Type Dementia

NCT07251023 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

450

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Type Dementia

Interventions

DRUG: DMB-I (INN: Latrepirdine)
DRUG: Memantine Hydrochloride 20 MG
DRUG: Placebo

Sponsor

Bigespas LTD